EP1520023 - HUMAN NUCLEAR HORMONE RECEPTOR [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 23.12.2005 Database last updated on 02.11.2024 | Most recent event Tooltip | 23.12.2005 | Withdrawal of application | published on 08.02.2006 [2006/06] | Applicant(s) | For all designated states Inpharmatica Limited 60 Charlotte Street London W1T 2NU / GB | [2005/14] | Inventor(s) | 01 /
PHELPS, Christopher, Benjamin Inpharmatica Limited, 60 Charlotte Street London W1T 2NU / GB | 02 /
FAGAN, Richard, Joseph Impharmatica Limited, 60 Charlotte Street London W1T 2NU / GB | 03 /
ALLEN, Kathryn, Elizabeth Inpharmatica Limited, 60Charlotte Street London W1T 2NU / GB | 04 /
STANCOVSKI, Ilana Inpharmatica Limited,60 Charlotte Street London W1T 2NU / GB | 05 /
PIERRON, Valerie, Nathalie Inpharmatica Limited, 60 Charlotte Street London W1T 2NU / GB | 06 /
PHILLIPS, Tom Inpharmatica Limited, 60 Charlotte Street London W1T 2NU / GB | 07 /
HUNT, Caroline, Ann Inpharmatica Limited,60 Charlotte Street London W1T 2NU / GB | 08 /
ENAYAT, Zinat, Ellaheh Inpharmatica Limited,60 Charlotte Street London W1T 2NU / GB | 09 /
ALLEN, Janet, Marjorie Inpharmatica Limited 60 Charlotte Street London W1T 2NU / GB | [2005/14] | Representative(s) | Goodfellow, Hugh Robin Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [2005/14] | Goodfellow, Hugh Robin Carpmaels & Ransford, 43 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 03738307.2 | 03.07.2003 | [2005/14] | WO2003GB02848 | Priority number, date | GB20020015406 | 03.07.2002 Original published format: GB 0215406 | [2005/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004005346 | Date: | 15.01.2004 | Language: | EN | [2004/03] | Type: | A2 Application without search report | No.: | EP1520023 | Date: | 06.04.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.01.2004 takes the place of the publication of the European patent application. | [2005/14] | Search report(s) | International search report - published on: | EP | 29.04.2004 | Classification | IPC: | C12N15/12, C07K14/72, C07K16/28, C12Q1/68, G01N33/53, G01N33/50, C12N5/10, A61K38/17, A61K39/00, A01K67/027 | [2005/14] | CPC: |
C07K14/70567 (EP);
A01K2217/05 (EP);
A61K38/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/14] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | HUMANER NUKLEÄRER HORMONREZEPTOR | [2005/14] | English: | HUMAN NUCLEAR HORMONE RECEPTOR | [2005/14] | French: | RECEPTEUR DE L'HORMONE NUCLEAIRE | [2005/14] | Entry into regional phase | 31.01.2005 | National basic fee paid | 31.01.2005 | Designation fee(s) paid | 31.01.2005 | Examination fee paid | Examination procedure | 31.01.2005 | Examination requested [2005/14] | 07.12.2005 | Application withdrawn by applicant [2006/06] | Fees paid | Renewal fee | 31.01.2005 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO0058473 (CURAGEN CORPORATION) [X] 1,7-15,19-24,28,32-45 * the whole document * * see especially:; page 262; table 1 * * page 410; table 2 * * page 411; table 2 * * page 414; table 2 * * page 420; table 2 * * page 3248 - page 3249 * * SEQ ID NOS: 4061 and 4062 and; page 5503 - page 5507; claims 1-32 *; | [PX]WO02070539 (HYSEQ, INC.) [PX] 1,7-15,19-24,28,32-45 * the whole document * * see especially:; page 107; table 1 * * page 111; table 1 * * page 114; table 1 * * page 120; table 1 * * page 1002; table 8 * * and; page 1008 - page 1011; claims 1-27 *; | [PX]WO02070539 (HYSEQ, INC.) [PX] 1,7-15,19-24,28,32-45 * the whole document * * see especially:; page 208; table 2 * * page 1002; table 8 * * and; page 1008 - page 1011; claims 1-27 *; | [X] - NAGASE, T. ET AL., "Predicton of the Coding Sequences of Unidentified Human Genes. XVIII. The Complete Sequences of 100 New cDNA Clones from Brain Which Code for Large Proteins in vitro", DNA RESEARCH, (20000831), vol. 7, no. 4, pages 273 - 281, XP001012454 [X] 1,7-15,19-24,28,32-45 * the whole document * * see especially:; page 274; figure 1 * * page 275; table 1 * * and; page 280; figure 3 * | [DX] - NAGASE, T. ET AL., "KIAA1577 protein [Homo sapiens]", NCBI PROTEIN DATABASE, (20010222), Database accession no. BAB13403, XP002268259 [DX] 1,7-15,19-24,28,32-45 * the whole document * | [X] - EGEA, P.F. ET AL., "Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid", EMBO JOURNAL, (20000601), vol. 19, no. 11, pages 2592 - 2601, XP002268433 [X] 1,6,8-15,19-24,28-30,32-45 * the whole document * DOI: http://dx.doi.org/10.1093/emboj/19.11.2592 | [L] - "Human polynucleotide SEQ ID NO: 648", EMBL, (20030120), Database accession no. ABZ11766, XP002268260 [L] * the whole document * * cited to provide information on the relevant sequence disclosed in WO02070539 * | [L] - "Human polypeptide SEQ ID NO: 1596", EMBL, (20030120), Database accession no. ABP69549, XP002268261 [L] * the whole document * * cited to provide information on the relevant sequence disclosed in WO02070539 * | [X] - NCI-CGAP, "nl50d03.s1 NCI_CGAP_Pr4 Homo sapiens cDNA clone IMAGE: 1044101, mRNA sequence", EMBL, (19970911), Database accession no. AA558357, XP002268262 [X] 1,7-15,19-24,28,32-45 * the whole document * | [X] - ADAMS, M.D. ET AL., "EST96990 Testis I Homo sapiens cDNA 5' end", EMBL, (19970418), Database accession no. AA383339, XP002268263 [X] 1,7-15,19-24,28,32-45 * the whole document * | [A] - EGEA, P.F. ET AL., "Molecular Recognition of Agonist Ligands by RXRs", MOLECULAR ENDOCRINOLOGY, (200205), vol. 16, no. 5, pages 987 - 997, XP002268434 [A] 1-15,19-24,28-45 * the whole document * * see especially:; page 988, column 1, line 44 - line 50 * DOI: http://dx.doi.org/10.1210/me.16.5.987 |